About RxLightning
RxLightning is a private company based in New Albany, Indiana, incorporated in 2020 in Delaware. It has reported $25,849,950 raised in three offerings on Form D since April 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 25, 2023 | Jun 6, 2023 | $17,499,950fully sold | 12 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Apr 1, 2022 | Apr 15, 2022 | $5,350,000of $5.5M target | 7 | $764K | Securities on exercise, SAFE (Simple Agreement Future Equity)Rule 506(b) | Form D ↗ |
| Apr 14, 2021 | Apr 16, 2021amended Apr 27, 2021 | $3,000,000fully sold | 14 | $214K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $25,849,950 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on RxLightning's Form D filed Jun 6, 2023.
JK
Jared Klingeisen
Executive officer
BF
Bradley Fluegel
Director
JR
Julia Regan
President and director
JF
Josh Flum
Director
MB
Mark Bakken
Director
KB
Kathleen Bresette
Executive officer
CW
Carrie Williams
Director
BA
Brad Allen
Executive officer
Earlier filings also listed Taha Jangda (director, last listed Apr 2022) and Richard Cohan (director, last listed Apr 2022).